NCT06080048View on ClinicalTrials.gov

A Clinical Trial to Assess the Safety of SOR102 in Healthy Participants and Patients With Ulcerative Colitis

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

October 24, 2023

Primary Completion Date

October 16, 2024

Study Completion Date

November 8, 2024

Conditions
Ulcerative Colitis
Interventions
DRUG

SOR102

SOR102 capsules

DRUG

Placebo

Matching placebo capsules

Trial Locations (2)

Unknown

Arensia Exploratory Medicine, Tbilisi

Arensia Exploratory Medicine, Kyiv

All Listed Sponsors
lead

Sorriso Pharmaceuticals, Inc.

INDUSTRY

NCT06080048 - A Clinical Trial to Assess the Safety of SOR102 in Healthy Participants and Patients With Ulcerative Colitis | Biotech Hunter | Biotech Hunter